Study of the Anticancer Properties of Tin(IV) Carboxylate Complexes on a Panel of Human Tumor Cell Lines

ChemMedChem

Volumn 7, Issue 2, 2012, Pages 301-310

  Rocamora Reverte, Lourdes ^a   Carrasco García, Estefanía ^a   Ceballos Torres, Jesús ^b   Prashar, Sanjiv ^b   Kaluderović, Goran N ^c   Ferragut, José A ^a   Gómez Ruiz, Santiago ^b  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Antitumor agents; Apoptosis; Cell cycle; Drug resistance; Tin

Indexed keywords

1,4 BENZODIOXANE 6 CARBOXYLIC ACID; 2,5 DIMETHYL 3 FUROIC ACID; 2,6 DIMETHOXYNICOTINIC ACID; ANTINEOPLASTIC AGENT; GLYCOPROTEIN P; ORGANOTIN COMPOUND; TRICYCLOHEXYLTIN(IV)CHLORIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; DRUG SYNTHESIS; ERYTHROLEUKEMIA; GLIOBLASTOMA; HUMAN; HUMAN CELL; PANCREAS CARCINOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CARBOXYLIC ACIDS; CELL LINE, TUMOR; CELL PROLIFERATION; COORDINATION COMPLEXES; CRYSTALLOGRAPHY, X-RAY; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MOLECULAR CONFORMATION; P-GLYCOPROTEIN; TIN;

EID: 84856383057     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201100432     Document Type: Article

References (67)

1. B. Rosenberg, L. VanCamp, J. E. Trosko, V. H. Mansour, Nature 1969, 222, 385-386.
2. Platinum and Other Coordination Compounds in Cancer Chemotherapy (Ed.: M. Nikolini), Martinus-Nijhoff Publishing, Boston, MA, 1988.
3. I. Ott, R. Gust, Arch. Pharm. 2007, 340, 117-126.
4. M. A. Jakupec, M. Galanski, V. B. Arion, C. G. Hartinger, B. K. Keppler, Dalton Trans. 2008, 183-194.
5. M. Gielen, Coord. Chem. Rev. 1996, 151, 41-51.
6. P. Yang, M. Guo, Coord. Chem. Rev. 1999, 185, 189-211.
7. S. K. Hadjikakou, N. Hadjiliadis, Coord. Chem. Rev. 2009, 253, 235-249.
8. K. Strohfeldt, M. Tacke, Chem. Soc. Rev. 2008, 37, 1174-1187.
9. P. M. Abeysinghe, M. M. Harding, Dalton Trans. 2007, 3474-3482.
10. R. Gust, D. Posselt, K. Sommer, J. Med. Chem. 2004, 47, 5837-5846.
11. C. G. Hartinger, P. J. Dyson, Chem. Soc. Rev. 2009, 38, 391-401.
12. P. C. A. Bruijnincx, P. J. Sadler, Adv. Inorg. Chem. 2009, 61, 1-62.
13. P. C. A. Bruijnincx, P. J. Sadler, Curr. Opin. Chem. Biol. 2008, 12, 197-206.
14. Y. K. Yan, M. Melchart, A. Habtemariam, P. J. Sadler, Chem. Commun. 2005, 4764-4776.
15. M. Nath, S. Pokharia, R. Yadav, Coord. Chem. Rev. 2001, 215, 99-149.
16. M. Gielen, R. Willem in Cytotoxic, Mutagenic and Carcinogenic Potential of Heavy Metals Related to Human Environment, NATO ASI Series 2: Environment, Vol.26 (Ed.: N.D. Hadjiliadis), Kluwer Academic, Dordrecht/Boston/London, 1997, pp.445-455.
17. D. DeVos, R. Willem, M. Gielen, K. E. VanWingerden, K. Nooter, Met.-Based Drugs 1998, 5, 179-188.
18. C. Pettinari, Main Group Met. Chem. 1999, 22, 661-692.
19. A. J. Crowe, "Antitumor Activity of Tin Compounds" in Metal Compounds in Cancer Therapy (Ed.: S.P. Flicker), Chapman & Hall, London, 1994, pp.147-179.
20. A. K. Saxena, F. Huber, Coord. Chem. Rev. 1989, 95, 109-123.
21. J. Susperregui, M. Bayle, G. Lain, C. Giroud, T. Baltz, G. Deleris, Eur. J. Med. Chem. 1999, 34, 617-623.
22. L. Pellerito, L. Nagy, Coord. Chem. Rev. 2002, 224, 111-150 and references therein.
23. Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine (Eds.: M. Gielen, E.R.T. Tiekink), Wiley, Chichester, 2005, p.421.
24. T. S. BasuBaul, W. Rynjah, E. Rivarola, A. Lycka, M. Holcapek, R. Jirasko, D. DeVos, R. J. Butcher, A. Linden, J. Organomet. Chem. 2006, 691, 4850-4862.
25. L. Tian, Y. Sun, H. Li, X. Zheng, Y. Cheng, X. Liu, B. Qian, J. Inorg. Biochem. 2005, 99, 1646-1652.
26. G. Han, P. Yang, J. Inorg. Biochem. 2002, 91, 230-236.
27. S. Gómez-Ruiz, G. N. Kaluderović, S. Prashar, E. Hey-Hawkins, A. Erić, Ž. Žižak, Z. D. Juranić, J. Inorg. Biochem. 2008, 102, 2087-2096.
28. M. L. Falcioni, M. Pellei, R. Gabbianelli, Mutat. Res. 2008, 653, 57-62 and references therein.
29. Q. Li, P. Yang, H. Wang, M. Guo, J. Inorg. Biochem. 1996, 64, 181-195.
30. J. S. Casas, E. E. Castellano, M. D. Couce, J. Ellena, A. Sanchez, J. L. Sanchez, J. Sordo, C. Taboada, Inorg. Chem. 2004, 43, 1957-1963.
31. Y. Arakawa, Biomed. Res. Trace Elem. 2000, 11, 259-286.
32. C. Syng-Ai, T. S. BasuBaul, A. Chatterijee, J. Environ. Pathol. Toxicol. Oncol. 2001, 20, 333-342.
33. F. Barbieri, M. Viale, F. Sparatore, G. Schettini, A. Favre, C. Bruzzo, F. Novelli, A. Alema, Anticancer Drugs 2002, 13, 599-604.
34. H. Seibert, S. Moerchel, M. Guelden, Cell. Biol. Toxicol. 2004, 20, 273-283.
35. N. Höti, J. Ma, S. Tabassum, Y. Wang, M. Wu, J. Biochem. 2003, 134, 521-528.
36. S. Gómez-Ruiz, G. N. Kaluderović, D. Polo-Cerón, S. Prashar, M. Fajardo, Ž. Žižak, Z. D. Juranić, T. J. Sabo, Inorg. Chem. Commun. 2007, 10, 748-752.
37. S. Gómez-Ruiz, G. N. Kaluderović, S. Prashar, D. Polo-Cerón, M. Fajardo, Ž. Žižak, T. J. Sabo, Z. D. Juranić, J. Inorg. Biochem. 2008, 102, 1558-1570.
38. M. E. Kelly, A. Dietrich, S. Gómez-Ruiz, B. Kalinowski, G. N. Kaluderović, T. Müller, R. Paschke, J. Schmidt, D. Steinborn, C. Wagner, H. Schmidt, Organometallics 2008, 27, 4917-4927.
39. D. Pérez-Quintanilla, S. Gómez-Ruiz, Ž. Žižak, I. Sierra, S. Prashar, I. delHierro, M. Fajardo, Z. D. Juranić, G. N. Kaluderović, Chem. Eur. J. 2009, 15, 5588-5597.
40. S. Gómez-Ruiz, B. Gallego, M. R. Kaluderović, H. Kommera, E. Hey-Hawkins, R. Paschke, G. N. Kaluderović, J. Organomet. Chem. 2009, 694, 2191-2197.
41. S. Gómez-Ruiz, B. Gallego, Ž. Žižak, E. Hey-Hawkins, Z. D. Juranić, G. N. Kaluderović, Polyhedron 2010, 29, 354-360.
42. S. Gómez-Ruiz, S. Prashar, T. Walther, M. Fajardo, D. Steinborn, R. Paschke, G. N. Kaluderović, Polyhedron 2010, 29, 16-23.
43. M. R. Kaluderović, S. Gómez-Ruiz, B. Gallego, E. Hey-Hawkins, R. Paschke, G. N. Kaluderović, Eur. J. Med. Chem. 2010, 45, 519-525.
44. G. N. Kaluderović, D. Pérez-Quintanilla, I. Sierra, S. Prashar, I. delHierro, Ž. Žižak, Z. D. Juranić, M. Fajardo, S. Gómez-Ruiz, J. Mater. Chem. 2010, 20, 806-814.
45. G. N. Kaluderović, D. Pérez-Quintanilla, Ž. Žižak, Z. D. Juranić, S. Gómez-Ruiz, Dalton Trans. 2010, 39, 2597-2608.
46. S. V. Ambudkar, S. Dey, C. A. Hrycyna, M. Ramachandra, I. Pastan, M. M. Gottesman, Annu. Rev. Pharmacol. Toxicol. 1999, 39, 361-398.
47. P. Borst, R. Evers, M. Kool, J. Wijnholds, J. Natl. Cancer Inst. 2000, 92, 1295-1301.
48. M. M. Gottesman, Annu. Rev. Med. 2002, 53, 615-627.
49. G. B. Deacon, R. J. Philips, Coord. Chem. Rev. 1980, 33, 227-250.
50. A. R. Forrester, S. J. Garden, R. A. Howie, J. L. Wardell, J. Chem. Soc. Dalton Trans. 1992, 2615-2621.
51. H. D. Yin, Q. B. Wang, S. C. Xue, J. Organomet. Chem. 2005, 690, 435-440.
52. M. M. Gottesman, I. Pastan, Annu. Rev. Biochem. 1993, 62, 385-427.
53. B. Sarkadi, L. Homolya, G. Szakács, A. Váradi, Physiol. Rev. 2006, 86, 1179-1236.
54. M. M. Gottesman, V. Ling, FEBS Lett. 2006, 580, 998-1009.
55. M. D. Castro-Galache, J. A. Ferragut, V. Barbera, E. Martin-Orozco, J. M. Gonzalez-Ros, P. García-Morales, M. Saceda, Int. J. Cancer 2003, 104, 579-586.
56. T. Tsuruo, H. Iida, S. Tsukagoshi, Y. Sakurai, Cancer Res. 1982, 42, 4730-4733.
57. C. P. Wu, A. M. Calcagno, S. V. Ambudkar, Curr. Mol. Pharmacol. 2008, 1, 93-105.
58. A. B. Shapiro, V. Ling, Eur. J. Biochem. 1997, 250, 130-137.
59. W. B. Pratt, R. W. Ruddon, W. D. Ensminger, J. Maybaum, The Anticancer Drugs, Oxford University Press, New York, 1994, pp.155-182.
60. D. E. Fisher, Cell 1994, 78, 539-542.
61. M. J. Smyth, E. Krasovkis, V. R. Sutton, R. W. Johnstone, Proc. Natl. Acad. Sci. USA 1998, 95, 7024-7029.
62. SCALE3 ABSPACK: Empirical absorption correction, CrysAlis software package, Oxford Diffraction Ltd., 2006.
63. G.M. Sheldrick, SHELXS-97, Program for Crystal Structure Solution, Göttingen (Germany), 1997.
64. G.M. Sheldrick, SHELXL-97, Program for the Refinement of Crystal Structures, Göttingen (Germany), 1997.
65. M. D. Castro-Galache, M. P. Menendez-Gutierrez, E. Carrasco-García, P. García-Morales, I. Martinez-Lacaci, M. Saceda, J. A. Ferragut, Int. J. Biochem. Cell Biol. 2007, 39, 1877-1885.
66. T. Mosmann, J. Immunol. Methods 1983, 65, 55-63.
67. M. V. Camarasa, M. D. Castro-Galache, E. Carrasco-García, P. García-Morales, M. Saceda, J. A. Ferragut, J. Cell. Biochem. 2005, 94, 98-108.